Abeona Therapeutics Inc (ABEO)
Abeona Therapeutics stock today
Abeona Therapeutics closed at $4.35 on October 30, 2026, down 4.61% on the day. Over the past year it returned -14.4% with dividends reinvested, against +12.4% for the S&P 500. Its market value is $248 million.
| Period | ABEO | S&P 500 (SPY) |
|---|---|---|
| 1 month | -17.1% | -0.9% |
| 3 months | -32.8% | +2.1% |
| Year to date | -17.5% | +11.7% |
| 1 year | -14.4% | +12.4% |
| 3 years | +14.8% | +88.5% |
| 5 years | -78.6% | +76.0% |
Key statistics
- Market value
- $248M
- Price / sales
- 9.7
- 52-week range
- $4.17 to $7.46
- Next report
- Nov 11, 2026
About Abeona Therapeutics
Develops gene therapy treatments for genetic and rare diseases.
Sector: Health Care
More on Abeona Therapeutics
- Financials: revenue, earnings and segmentsRevenue +66% in the year to Dec 2025
- Returns: what $1,000 became$1,000 ten years ago is $24.68 today
No forecast, no recommendation. This page describes Abeona Therapeutics Inc from published data; it is not advice to buy, sell or hold any security.
Figures as of the close on Oct 30, 2026 unless a row says otherwise. Prices are split adjusted; returns include dividends reinvested. Data may be delayed. See the disclaimer and how TrendArc works.